Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Suspended NCT03722303

Lipografting Versus Steroid Injections for Treatment of Carpal Tunnel Syndrome

Conditions: Carpal Tunnel Syndrome

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: Yes

Phase: EARLY_PHASE1

Enrollment: 100

Sponsor: Columbia University

Location: Columbia University Irving Medical Center New York New York

Summary

This study applies the regenerative properties of autologous fat transfer to treat mild to moderate carpal tunnel syndrome in comparison to the current standard of care, corticosteroid treatment. The investigators hypothesize the fat transfer would prevent scar formation and aid in nerve excursion along the canal (while the neoangiogenic and regenerative growth factors could stimulate nerve regeneration) better than the standard of care treatment.

Eligibility Criteria

Inclusion Criteria: * primary mild to moderate carpal tunnel syndrome (CTS) * report symptoms longer than 6 months * night pain * weakness * sensory deficits * fluent English-speaking adult (\>18) Exclusion Criteria: * \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT03722303). StuddyBuddy aggregates publicly available trial information.